Elutia Inc. (ELUT)
NASDAQ: ELUT · Real-Time Price · USD
1.010
-0.010 (-0.98%)
At close: Apr 28, 2026, 4:00 PM EDT
1.000
-0.010 (-0.99%)
After-hours: Apr 28, 2026, 4:04 PM EDT
Elutia Revenue
In the year 2025, Elutia had annual revenue of $12.29M, down -15.03%. Elutia had revenue of $3.27M in the quarter ending December 31, 2025, with 16.16% growth.
Revenue (ttm)
$12.29M
Revenue Growth
-15.03%
P/S Ratio
3.55
Revenue / Employee
$472,808
Employees
26
Market Cap
43.21M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Accuray | 436.97M |
| Nortech Systems | 118.37M |
| Pulmonx | 90.50M |
| TELA Bio | 80.28M |
| Cytosorbents | 37.06M |
| electroCore | 32.03M |
| NeuroOne Medical Technologies | 11.72M |
| Picard Medical | 4.94M |
ELUT News
- 5 weeks ago - Elutia Transcript: Sidoti March Small-Cap Virtual Conference - Transcripts
- 6 weeks ago - Elutia to Present at Sidoti's Small-Cap Virtual Investor Conference March 18-19 - GlobeNewsWire
- 6 weeks ago - Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - Elutia Earnings Call Transcript: Q4 2025 - Transcripts
- 6 weeks ago - Elutia Reports Fourth Quarter and Full Year 2025 Financial Results; Initiates NXT-41 Regulatory Process - GlobeNewsWire
- 7 weeks ago - Elutia Regains Compliance with Nasdaq Listing Requirements - GlobeNewsWire
- 2 months ago - Elutia Selects Pete Ligotti as CCO to Lead the Commercial Launch of NXT-41x and Transform Post-Mastectomy Care in the $1.5B U.S. Breast Surgery Market - GlobeNewsWire
- 2 months ago - Elutia to Report Fourth Quarter 2025 Financial Results on Wednesday, March 11, 2026 - GlobeNewsWire